Ingenuity Systems appoints SeouLin Bioscience as exclusive distributor of IPA software in South Korea

NewsGuard 100/100 Score

Ingenuity Systems, the leading provider of information solutions for life science researchers, today announced the appointment of SeouLin Bioscience Co., Ltd. as the exclusive distributor of IPA in South Korea.

"Ingenuity is excited to partner with SeouLin Bioscience – they are a recognized leader in Korea for microarray, cell signaling, and genomics and proteomics products and services," stated Sean Scott, Senior Vice President, Commercial Operations, Ingenuity Systems.  "SeouLin's customers can now take advantage of IPA in order to optimize experiment to experiment workflows and accelerate the production of breakthrough research, grants, and publications. We are pleased to make IPA more widely available in the Korean research community."

This partnership is the latest expansion for Ingenuity Systems in the Asia Pacific market.  Ingenuity products and services are already distributed in Singapore, Taiwan, Japan, and Australia and New Zealand.

"IPA will provide a powerful addition to SeouLin's portfolio of life science products and services," says EulMoon Hwang, President & CEO, SeouLin Bioscience.  "IPA will provide our Korean researchers with a powerful and reliable solution to formulate better hypotheses, design better experiments, and analyze, integrate, and understand their 'omics data."

Source:

Ingenuity Systems

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study reveals significant health benefits of golden berries in diabetic and obese rats